Smoking Cessation Outcomes among Individuals with Substance Use and/or Psychiatric Disorders
Received Date: Sep 06, 2011 / Accepted Date: Oct 19, 2011 / Published Date: Oct 24, 2011
Objectives: The population of individuals with substance use (SUD) and/or psychiatric disorders (PD) has a high prevalence of smoking and a consequent increase in tobacco-related morbidity and mortality when compared to the general population. The aim of this study is to examine the outcomes of a program in a real-life setting which takes a tailored approach to smoking cessation among individuals with SUD and/or PD.
Methods: A retrospective chart review of tailored tobacco dependence treatment was performed on individuals with histories of SUD and/or PD attending a Tobacco Dependence Clinic (TDC) program in Vancouver, British Columbia, Canada. Participants of the TDC received a combination of behavioural counselling and pharmacotherapy for smoking cessation. Data from 540 participants enrolled in the TDC between September 2007 and May 2011 was reviewed. Outcome measures included seven-day point-prevalence abstinence (validated by expired carbon monoxide) and program completion rates.
Results: For individuals who completed the program the abstinence rate was 41.1% (167/406). Significant predictors of successful smoking cessation were: a) a lower expired carbon monoxide level at baseline (OR=.98, 95%CI=.96-1.00), and b) a longer duration of treatment (OR=1.09, 95%CI=1.05-1.12). Significant predictors of program completion were: a) being female (OR=1.86, 95%CI=1.21-2.87).
Discussion: Tailored smoking cessation among individuals with SUD and/or PD yields modest end-of-treatment smoking cessation rates and can be an effective approach to reducing the burden of tobacco use in substance use and mental health treatment settings.
Keywords: Smoking cessation (SC); Substance use disorders (SUD); Psychiatric disorders (PD); Tailored interventions
Citation: Khara M, Okoli CTC (2011) Smoking Cessation Outcomes among Individuals with Substance Use and/or Psychiatric Disorders. J Addict Res Ther 2:115. Doi: 10.4172/2155-6105.1000115
Copyright: © 2011 Khara M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 13574
- [From(publication date): 10-2011 - Jun 21, 2021]
- Breakdown by view type
- HTML page views: 9724
- PDF downloads: 3850